Ha habido 50 transacciones internas recientes registradas para Pieris Pharmaceuticals, Inc. (PIRS), incluyendo 42 compras y 5 ventas. El total de compras internas fue valorado en $12.03M y el total de ventas internas en $2.66M.
Internos destacados con actividad reciente incluyen Geraghty James A, Kiritsy Christopher P, Dellora Investments Lp. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — PIRS
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-12-12 |
Geraghty James A |
Director |
Devolución de Acciones |
1 |
$0.01 |
$0.01 |
- |
| 2024-12-02 |
Kiritsy Christopher P |
Director |
Concesión de RSU |
500 |
$16.43 |
$8.22K |
500 |
| 2024-11-06 |
Dellora Investments Lp |
10 Percent Owner |
Desconocido |
- |
- |
- |
141,079 |
| 2024-08-12 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Compra Informativa |
757 |
$15.88 |
$12.02K |
15,067 |
| 2024-08-09 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Compra Informativa |
3,000 |
$14.89 |
$44.68K |
127,331 |
| 2024-08-07 |
Geraghty James A |
Director |
Compra Informativa |
1 |
$1.00 |
$1.00 |
1 |
| 2024-07-24 |
Adar1 Capital Management, Llc |
10 Percent Owner |
Desconocido |
- |
- |
- |
14,310 |
| 2023-06-21 |
Geraghty James A |
Director |
Concesión de RSU |
45,000 |
$0.26 |
$11.7K |
45,000 |
| 2023-06-21 |
Kiritsy Christopher P |
Director |
Concesión de RSU |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Sherman Matthew L |
Director |
Concesión de RSU |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Kiener Peter A |
Director |
Concesión de RSU |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Richman Michael |
Director |
Concesión de RSU |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Barbier Ann |
Director |
Concesión de RSU |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-06-21 |
Said Maya R. |
Director |
Concesión de RSU |
40,000 |
$0.26 |
$10.4K |
40,000 |
| 2023-05-25 |
Kiritsy Christopher P |
Director |
Compra Informativa |
10,000 |
$0.85 |
$8.5K |
20,000 |
| 2023-05-11 |
Bvf Partners L P/il |
10 Percent Owner |
Disposición |
265,000 |
$7.10 |
$1.88M |
- |
| 2023-02-24 |
Yoder Stephen S. |
Chief Executive Officer |
Concesión de RSU |
634,021 |
$1.39 |
$881.29K |
634,021 |
| 2023-02-24 |
Bures Thomas |
Chief Financial Officer |
Concesión de RSU |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2023-02-24 |
Kaufmann Hitto |
Chief Scientific Officer |
Concesión de RSU |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2023-02-24 |
Olwill Shane |
Chief Development Officer |
Concesión de RSU |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2023-02-24 |
Mousa Ahmed |
Chief Business Officer |
Concesión de RSU |
249,080 |
$1.39 |
$346.22K |
249,080 |
| 2022-06-22 |
Geraghty James A |
Director |
Concesión de RSU |
45,000 |
- |
- |
45,000 |
| 2022-06-22 |
Kiritsy Christopher P |
Director |
Concesión de RSU |
40,000 |
$1.82 |
$72.8K |
40,000 |
| 2022-06-22 |
Sherman Matthew L |
Director |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2022-06-22 |
Kiener Peter A |
Director |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2022-06-22 |
Richman Michael |
Director |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2022-06-22 |
Barbier Ann |
Director |
Concesión de RSU |
40,000 |
$1.82 |
$72.8K |
40,000 |
| 2022-06-22 |
Said Maya R. |
Director |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2022-05-13 |
Demuth Tim |
Chief Medical Officer |
Compra Informativa |
6,000 |
$1.71 |
$10.26K |
6,000 |
| 2022-02-22 |
Yoder Stephen S. |
Chief Executive Officer |
Concesión de RSU |
625,874 |
$3.03 |
$1.9M |
625,874 |
| 2022-02-22 |
Bures Thomas |
Chief Financial Officer |
Concesión de RSU |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2022-02-22 |
Kaufmann Hitto |
SVP, Chief Scientific Officer |
Concesión de RSU |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2022-02-22 |
Demuth Tim |
Chief Medical Officer |
Concesión de RSU |
100,000 |
$3.03 |
$303K |
100,000 |
| 2022-02-22 |
Olwill Shane |
Chief Development Officer |
Concesión de RSU |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2022-02-22 |
Mousa Ahmed |
Chief Business Officer |
Concesión de RSU |
215,819 |
$3.03 |
$653.93K |
215,819 |
| 2021-10-06 |
Mousa Ahmed |
Chief Business Officer |
Disposición |
150,000 |
$2.50 |
$375K |
- |
| 2021-08-30 |
Olwill Shane |
Chief Development Officer |
Venta Informativa |
29,200 |
$5.15 |
$150.38K |
4,638 |
| 2021-08-01 |
Demuth Tim |
Officer |
Desconocido |
- |
- |
- |
- |
| 2021-08-01 |
Demuth Tim |
Chief Medical Officer |
Concesión de RSU |
360,000 |
$3.48 |
$1.25M |
360,000 |
| 2021-08-01 |
Olwill Shane |
Chief Development Officer |
Disposición |
82,000 |
$3.09 |
$253.38K |
- |
| 2021-06-25 |
Geraghty James A |
Director |
Concesión de RSU |
45,000 |
$4.00 |
$180K |
45,000 |
| 2021-06-25 |
Kiritsy Christopher P |
Director |
Concesión de RSU |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Sherman Matthew L |
Director |
Concesión de RSU |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Kiener Peter A |
Director |
Concesión de RSU |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Richman Michael |
Director |
Concesión de RSU |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Barbier Ann |
Director |
Concesión de RSU |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-06-25 |
Said Maya R. |
Director |
Concesión de RSU |
40,000 |
$4.00 |
$160K |
40,000 |
| 2021-03-04 |
Yoder Stephen S. |
Chief Executive Officer |
Concesión de RSU |
530,000 |
$2.50 |
$1.33M |
530,000 |
| 2021-03-04 |
Bures Thomas |
Vice President, Finance |
Concesión de RSU |
150,000 |
$2.50 |
$375K |
150,000 |
| 2021-03-04 |
Kaufmann Hitto |
SVP, Chief Scientific Officer |
Concesión de RSU |
220,000 |
$2.50 |
$550K |
220,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
